Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMGN
DateTimeSourceHeadlineSymbolCompany
10/02/201911:01AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
10/02/201911:00AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
09/30/20197:09AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
09/29/20195:01AMBusiness WireImmunoGen Presents Initial Data from Phase 1b FORWARD II Triplet Cohort Evaluating Mirvetuximab Soravtansine in Combination w...NASDAQ:IMGNImmunoGen Inc
09/29/20191:31AMBusiness WireImmunoGen Presents Full Data from Phase 3 FORWARD I Study of Mirvetuximab Soravtansine in Ovarian Cancer at ESMONASDAQ:IMGNImmunoGen Inc
09/17/20195:30AMBusiness WireImmunoGen to Present Full Data from Phase 3 FORWARD I Study of Mirvetuximab Soravtansine & Initial Data from Phase 1b FORWARD...NASDAQ:IMGNImmunoGen Inc
08/07/20193:49PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMGNImmunoGen Inc
08/05/20197:56AMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:IMGNImmunoGen Inc
08/02/20199:34AMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:IMGNImmunoGen Inc
08/02/20195:39AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
08/02/20195:30AMBusiness WireImmunoGen Reports Recent Progress and Second Quarter 2019 Financial ResultsNASDAQ:IMGNImmunoGen Inc
07/22/201912:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/18/20193:30PMBusiness WireImmunoGen Announces Conference Call to Discuss Its Second Quarter 2019 Operating ResultsNASDAQ:IMGNImmunoGen Inc
07/02/201912:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/02/201912:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/02/201912:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/02/201912:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/02/201912:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/02/201912:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/01/20198:31AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/01/20198:30AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/27/20195:36AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
06/27/20195:30AMBusiness WireImmunoGen Announces Completion of Operational ReviewNASDAQ:IMGNImmunoGen Inc
06/24/201910:55AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
06/24/20199:26AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/24/20199:26AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/24/20199:26AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/24/20199:26AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/24/20199:25AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/24/20199:25AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN